questionsmedicales.fr
Phénomènes psychologiques
Processus mentaux
Perception
Perception visuelle
Perception visuelle : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Évaluation de la vision
Tests de vision
Imagerie par résonance magnétique
Électrorétinogramme
Troubles de la vision
Illusions visuelles
Ophtalmologie
Changements de vision
Maladies oculaires
Traumatismes oculaires
Symptômes
5
Vision floue
Difficultés de profondeur
Illusions visuelles
Perception visuelle
Agnosie
Troubles de la perception
Fatigue visuelle
Maux de tête
Synesthésie
Perception sensorielle
Prévention
5
Prévention des troubles visuels
Lunettes de soleil
Fatigue visuelle
Utilisation d'écrans
Tabagisme
Dégénérescence maculaire
Exercice physique
Santé oculaire
Traitements
5
Thérapie visuelle
Chirurgie oculaire
Thérapie visuelle
Coordination œil-main
Lunettes
Erreurs de réfraction
Chirurgie de la cataracte
Glaucome
Médicaments ophtalmiques
Glaucome
Complications
5
Perte de vision
Troubles émotionnels
Activités quotidiennes
Mobilité
Dépression
Isolement social
Aggravation des troubles
Traitement
Agnosie
Interactions sociales
Facteurs de risque
5
Âge
Antécédents familiaux
Diabète
Rétinopathie diabétique
Hypertension
Vaisseaux sanguins
Traumatismes oculaires
Risques visuels
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perception visuelle : Questions médicales les plus fréquentes",
"headline": "Perception visuelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perception visuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-29",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perception visuelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perception",
"url": "https://questionsmedicales.fr/mesh/D010465",
"about": {
"@type": "MedicalCondition",
"name": "Perception",
"code": {
"@type": "MedicalCode",
"code": "D010465",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clignement attentionnel",
"alternateName": "Attentional Blink",
"url": "https://questionsmedicales.fr/mesh/D054518",
"about": {
"@type": "MedicalCondition",
"name": "Clignement attentionnel",
"code": {
"@type": "MedicalCode",
"code": "D054518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.145"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception des couleurs",
"alternateName": "Color Perception",
"url": "https://questionsmedicales.fr/mesh/D003118",
"about": {
"@type": "MedicalCondition",
"name": "Perception des couleurs",
"code": {
"@type": "MedicalCode",
"code": "D003118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception du mouvement",
"alternateName": "Motion Perception",
"url": "https://questionsmedicales.fr/mesh/D009039",
"about": {
"@type": "MedicalCondition",
"name": "Perception du mouvement",
"code": {
"@type": "MedicalCode",
"code": "D009039",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.567"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Reconnaissance visuelle des formes",
"alternateName": "Pattern Recognition, Visual",
"url": "https://questionsmedicales.fr/mesh/D010364",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance visuelle des formes",
"code": {
"@type": "MedicalCode",
"code": "D010364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Reconnaissance faciale",
"alternateName": "Facial Recognition",
"url": "https://questionsmedicales.fr/mesh/D000066499",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance faciale",
"code": {
"@type": "MedicalCode",
"code": "D000066499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Clôture perceptive",
"alternateName": "Perceptual Closure",
"url": "https://questionsmedicales.fr/mesh/D010466",
"about": {
"@type": "MedicalCondition",
"name": "Clôture perceptive",
"code": {
"@type": "MedicalCode",
"code": "D010466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.677"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision binoculaire",
"alternateName": "Vision, Binocular",
"url": "https://questionsmedicales.fr/mesh/D015348",
"about": {
"@type": "MedicalCondition",
"name": "Vision binoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision monoculaire",
"alternateName": "Vision, Monocular",
"url": "https://questionsmedicales.fr/mesh/D015349",
"about": {
"@type": "MedicalCondition",
"name": "Vision monoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.893"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Perception visuelle",
"alternateName": "Visual Perception",
"code": {
"@type": "MedicalCode",
"code": "D014796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Farley Norman",
"url": "https://questionsmedicales.fr/author/J%20Farley%20Norman",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu."
}
},
{
"@type": "Person",
"name": "Matan Mazor",
"url": "https://questionsmedicales.fr/author/Matan%20Mazor",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Rani Moran",
"url": "https://questionsmedicales.fr/author/Rani%20Moran",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK."
}
},
{
"@type": "Person",
"name": "Stephen M Fleming",
"url": "https://questionsmedicales.fr/author/Stephen%20M%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Johan Wagemans",
"url": "https://questionsmedicales.fr/author/Johan%20Wagemans",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "No Association of Multiple Sclerosis with",
"datePublished": "2023-07-09",
"url": "https://questionsmedicales.fr/article/37511014",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411254"
}
},
{
"@type": "ScholarlyArticle",
"name": "The immunology of multiple sclerosis.",
"datePublished": "2022-05-04",
"url": "https://questionsmedicales.fr/article/35508809",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41577-022-00718-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ocrelizumab for multiple sclerosis.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35583174",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD013247.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Alemtuzumab for multiple sclerosis.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37272540",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD011203.pub3"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Multiple sclerosis treatments].",
"datePublished": "2023-03-23",
"url": "https://questionsmedicales.fr/article/37037639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.soin.2023.02.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes psychologiques",
"item": "https://questionsmedicales.fr/mesh/D011579"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus mentaux",
"item": "https://questionsmedicales.fr/mesh/D008606"
},
{
"@type": "ListItem",
"position": 4,
"name": "Perception",
"item": "https://questionsmedicales.fr/mesh/D010465"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perception visuelle",
"item": "https://questionsmedicales.fr/mesh/D014796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perception visuelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perception visuelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perception visuelle",
"description": "Comment évaluer la perception visuelle ?\nQuels examens pour troubles de la perception ?\nQuels signes indiquent un problème visuel ?\nQuand consulter un spécialiste de la vue ?\nQuelles sont les causes de troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Multiple+Sclerosis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perception visuelle",
"description": "Quels symptômes de troubles de la perception ?\nComment reconnaître une illusion visuelle ?\nQu'est-ce que l'agnosie visuelle ?\nQuels signes d'une fatigue visuelle ?\nComment se manifeste la synesthésie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Multiple+Sclerosis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perception visuelle",
"description": "Comment prévenir les troubles de la perception ?\nQuel rôle joue l'alimentation sur la vision ?\nComment réduire la fatigue visuelle ?\nPourquoi éviter le tabac pour la vision ?\nL'exercice physique aide-t-il la vision ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Multiple+Sclerosis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perception visuelle",
"description": "Quels traitements pour troubles de la perception ?\nComment la thérapie visuelle aide-t-elle ?\nLes lunettes corrigent-elles la perception ?\nQuand envisager une chirurgie oculaire ?\nQuels médicaments pour troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Multiple+Sclerosis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perception visuelle",
"description": "Quelles complications des troubles visuels ?\nComment les troubles visuels affectent-ils la vie quotidienne ?\nQuels risques de dépression avec troubles visuels ?\nLes troubles de la perception peuvent-ils s'aggraver ?\nQuelles sont les conséquences d'une agnosie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Multiple+Sclerosis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perception visuelle",
"description": "Quels facteurs de risque pour troubles visuels ?\nLe diabète augmente-t-il les risques visuels ?\nComment l'hypertension affecte-t-elle la vision ?\nLe stress influence-t-il la perception visuelle ?\nLes antécédents de traumatismes oculaires sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Multiple+Sclerosis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la perception visuelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de vision, comme l'optométrie, évaluent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels examens pour troubles de la perception ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème visuel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la vue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un ophtalmologiste si vous ressentez des changements soudains de vision."
}
},
{
"@type": "Question",
"name": "Quelles sont les causes de troubles visuels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de troubles de la perception ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une illusion visuelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'agnosie visuelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte."
}
},
{
"@type": "Question",
"name": "Quels signes d'une fatigue visuelle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la synesthésie visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la perception ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation sur la vision ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision."
}
},
{
"@type": "Question",
"name": "Comment réduire la fatigue visuelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour la vision ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il la vision ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour troubles de la perception ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment la thérapie visuelle aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie visuelle améliore la coordination œil-main et la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les lunettes corrigent-elles la perception ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie oculaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour troubles visuels ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires."
}
},
{
"@type": "Question",
"name": "Quelles complications des troubles visuels ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Comment les troubles visuels affectent-ils la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité."
}
},
{
"@type": "Question",
"name": "Quels risques de dépression avec troubles visuels ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles visuels augmentent le risque de dépression en raison de l'isolement social."
}
},
{
"@type": "Question",
"name": "Les troubles de la perception peuvent-ils s'aggraver ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une agnosie visuelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour troubles visuels ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il les risques visuels ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique."
}
},
{
"@type": "Question",
"name": "Comment l'hypertension affecte-t-elle la vision ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la perception visuelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la concentration et la clarté de la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes oculaires sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu.
Center for Applied Science in Health and Aging, Western Kentucky University, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu.
Publications dans "Perception visuelle" :
3 publications dans cette catégorie
Affiliations :
Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK.
Publications dans "Perception visuelle" :
3 publications dans cette catégorie
Affiliations :
Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.
Publications dans "Perception visuelle" :
3 publications dans cette catégorie
Affiliations :
Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK.
Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.
Department of Experimental Psychology, University College London, London, UK.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Humboldt-Universität zu Berlin, Berlin, Germany.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental Psychology, Justus Liebig University Giessen, 35394 Giessen, Germany, and Center for Mind, Brain and Behavior, Universities of Marburg, Giessen and Darmstadt, Germany. Electronic address: roland.w.fleming@psychol.uni-giessen.de.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Glendon College; and Center for Vision Research, York University, Toronto, Canada; email: patcav1@yorku.ca.
Publications dans "Perception visuelle" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Justus Liebig University Giessen, Giessen, Germany.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium. eline.vangeert@kuleuven.be.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Linguistics and Cognitive Science, University of Delaware, Newark, DE, USA. alon@udel.edu; https://pal.lingcogsci.udel.edu/.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Linguistics and Philosophy, Massachusetts Institute of Technology, Cambridge, MA, USA. ejgr@mit.edu; https://sites.google.com/site/greenedwinj/.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD, USA. chaz@jhu.edu; https://perception.jhu.edu/.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Psychiatry, Service of General Psychiatry, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Laboratory of Cognitive Neuroscience, Brain Mind Institute, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
Center for Neuroprosthetics, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Psychiatry, Service of General Psychiatry, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Center for Neuroprosthetics, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
CNRS, LPNC UMR 5105, Université Grenoble Alpes, Grenoble, France.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Lifeline Research Foundation, Lifeline Australia, Deakin ACT, Australia.
School of Health and Human Sciences, Southern Cross University, Lismore NSW, Australia.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Department of Mechanical Engineering and Automation, Northeastern University, Shenyang, China.
Publications dans "Perception visuelle" :
1 publication dans cette catégorie
Affiliations :
Institut de Neurosciences des Systèmes (INS), Inserm (U1106), Aix Marseille University, Marseille, France.
Publications dans "Perception visuelle" :
Multiple Sclerosis (MS) is a common immune-mediated disorder of the central nervous system that affects young adults and is characterized by demyelination and neurodegeneration. Recent studies have as...
Our incomplete understanding of the causes and pathways involved in the onset and progression of multiple sclerosis (MS) limits our ability to effectively treat this complex neurological disease. Rece...
Ocrelizumab is a humanised anti-CD20 monoclonal antibody developed for the treatment of multiple sclerosis (MS). It was approved by the Food and Drug Administration (FDA) in March 2017 for using in ad...
To assess the benefits, harms, and tolerability of ocrelizumab in people with RRMS and PPMS....
We searched MEDLINE, Embase, CENTRAL, and two trials registers on 8 October 2021. We screened reference lists, contacted experts, and contacted the main authors of studies....
All randomised controlled trials (RCTs) involving adults diagnosed with RRMS or PPMS according to the McDonald criteria, comparing ocrelizumab alone or associated with other medications, at the approv...
We used standard methodological procedures expected by Cochrane....
Four RCTs met our selection criteria. The overall population included 2551 participants; 1370 treated with ocrelizumab 600 mg and 1181 controls. Among the controls, 298 participants received placebo a...
For people with RRMS, ocrelizumab probably results in a large reduction in relapse rate and little to no difference in adverse events when compared with interferon beta-1a at 96 weeks (moderate-certai...
Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating and ...
To evaluate the benefits and harms of alemtuzumab alone or associated with other treatments in people with any form of MS....
We used standard, extensive Cochrane search methods. The latest search date was 21 June 2022....
We included randomized controlled trials (RCTs) in adults with any subtype of MS comparing alemtuzumab alone or associated with other medications versus placebo; another active drug; or alemtuzumab in...
We used standard Cochrane methods. Our co-primary outcomes were 1. relapse-free survival, 2. sustained disease progression, and 3. number of participants experiencing at least one adverse event. Our s...
We included three RCTs (1713 participants) comparing intravenous alemtuzumab versus subcutaneous interferon beta-1a for relapsing-remitting MS. Participants were treatment-naive (two studies) or had e...
Compared with interferon beta-1a, alemtuzumab may improve relapse-free survival and sustained disease progression-free survival, and make little to no difference on the proportion of participants with...
The last thirty years have led to the introduction of treatments that reduce the frequency of relapses and slow the progression of multiple sclerosis. They must be prescribed early, chosen according t...
Tuberous sclerosis (TS) is a monogenic disorder which causes disabling neurological symptoms. Similarly, multiple sclerosis (MS) may result in disability, but in contrast, is diagnosed without genetic...
The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS)....
MS typically affects young women in their childbearing years. Increasing evidence is available to inform questions raised by MS patients and health professionals about pregnancy issues....
The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and university databases (January 1975 through June 2021). The RAND/UCLA appropriateness method was developed to ...
A strong agreement was reached for all 104 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, locoregional ana...
The 2022 recommendations of the French MS society should be helpful to harmonise counselling and treatment practice for pregnancy in persons with MS, allowing for better and individualised choices....
The factor that is most relevant and strongly associated with the clinical course of multiple sclerosis is chronological age. Very young patients exclusively have relapsing remitting disease, whereas ...
Changes in the immune system associated with ageing are known as immunosenescence. This is characterised by a decline in immune response, chronic inflammation and an increased risk of autoimmune disea...
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, caused by an autoimmune reaction. Treatment options have largely increased over the years. In this article, we prese...